Mourning the Loss of Dr. Pierre Massion

Today, the American Lung Association mourns the loss of an esteemed lung cancer researcher, physician and scientist – Dr. Pierre Massion. Dr. Massion was a leading scientific mind in the field of lung cancer and a dedicated volunteer to the American Lung Association.

In addition to his role as Cornelius Vanderbilt Endowed Chair in Medicine at Vanderbilt University, Dr. Massion was an integral member of the Lung Association’s scientific team and was involved in all quarters of our work on lung cancer. Dr. Massion not only served on the Lung Association’s Scientific Advisory Committee and as chair of the review committee for the Lung Cancer Discovery Award, but he was also a passionate patient advocate who actively worked to improve early detection and diagnosis of lung cancer.

“Dr. Massion worked tirelessly to ensure patients had better access to screening, including through mobile screening sites,” said American Lung Association President and CEO Harold Wimmer. “In his dedication to patients and focus on saving more lives through research and screening, Dr. Massion truly exemplified what it means to be a champion of lung health.”

In addition to this tremendous work and volunteer service, he was also a prodigious researcher - authoring 170 publications on lung cancer and serving as principal investigator of 9 trials listed currently listed on clinicaltrials.gov. In recognition of his work, he was elected a fellow of the American Association for the Advancement of Science. His legacy will reach well beyond research alone, as he also mentored more than 21 postdoctoral fellows, 11 graduate students and 20 undergraduate students.

“The loss of Dr. Massion is sorely felt in our organization as well as the whole lung cancer community,” Wimmer said. “My heart goes out to Dr. Massion’s family and all those whose lives he touched.”

For more information, contact:

Allison MacMunn
312-801-7628
[email protected]

Freedom From Smoking Clinic
, | Sep 29, 2021
COPD Educator Course
, | Oct 20, 2021